The global airlift bioreactor market is primed for substantial growth, with new projections from Future Market Insights (FMI) estimating the market’s valuation at USD 2.4 billion in 2023 and forecasting a leap to USD 6.9 billion by 2033. This impressive expansion, expected at a compound annual growth rate (CAGR) of 11.2% over the next decade, signals the increasing relevance of airlift bioreactors in the evolving biotechnology and pharmaceutical sectors.
The rising demand for airlift bioreactors can be attributed to several key industry trends. Biotechnology is witnessing heightened research and development, driven by biopharmaceutical advancements and the increasing number of clinical and preclinical trials. Additionally, the demand for single-use bioreactors, valued for their efficiency and cost-effectiveness, is accelerating market growth.
“The airlift bioreactor market is on a robust growth path, fueled by expanding needs in biotechnology and pharmaceuticals,” an FMI representative stated. “With continued innovations in single-use bioreactors, we foresee sustained momentum that will support the market’s trajectory in the years ahead.”
Regional Dominance and Market Dynamics
North America is expected to lead the global airlift bioreactor market, thanks to its strong biotechnology and pharmaceutical infrastructure. The adoption of airlift bioreactors for the production of essential biological products—such as antibodies and vaccines—has positioned the region as a key market player.
Increased Market Demand: Get In-Depth Analysis and Insights with Our Complete Report!
Key Drivers of Airlift Bioreactor Demand
- Rising demand for biopharmaceuticals: The production of monoclonal antibodies, vaccines, and other biologic therapies to address diseases like cancer and viral infections relies heavily on airlift bioreactors.
- Focus on vaccine development: The COVID-19 pandemic highlighted the need for rapid and scalable vaccine production. Airlift bioreactors’ efficiency has proven indispensable to the biopharmaceutical industry, which is striving to meet growing global demands.
- Growth in drug discovery and preference for biologics: With the rising preference for biologics—drugs derived from living cells—airlift bioreactors are essential to supporting the intricate processes of drug discovery.
- Prevalence of chronic diseases: The increasing incidence of chronic illnesses, such as cancer and diabetes, is boosting the demand for innovative treatments. Airlift bioreactors play a pivotal role in producing these therapies efficiently.
The market potential for airlift bioreactors underscores their critical role in bioprocessing, positioning the technology as central to meeting the demands of a fast-evolving biotech landscape. Industry leaders are seizing opportunities to drive this expansion, underscoring a commitment to innovation and collaboration.
Some of the leading manufacturers and suppliers of airlift bioreactors are:
- Sartorius AG
- Lonza
- Shree Biocare
- Knik Technology
- Electrolab Biotech
- Rotech Inc.
- Cellexus
- Solida Biotech GmBH
- Zeta GmbH
- Kuhner shaker
Key segments:
By Product:
- Internal airlift loop bioreactor
- External airlift loop bioreactor
By Capacity:
- 5L
- 7L
- 10L
- 30L
By Material:
- Stainless steel
- Glass
By Usage:
- Single-use / disposal
- Reusable
By Production Scale:
- Laboratory scale
- Pilot-scale
- Large scale
By End-User:
- Biopharmaceutical companies
- Contract research organizations (CROs)/ Contract development and manufacturing organizations (CDMOs)
- Research and development companies
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
